Industry / Bosnia-Herzegovina
Bosnalijek Looking For Closer Ties With Libya
March 2008 | Industry NewsBosnalijek, the largest drugmaker in Bosnia and Herzegovina, is planning to increase its partnership with Libya's government. It is also looking to increase its co-operation with Libyan pharmaceutical firm Al Rabta, and may even consider a takeover bid.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
